Newron Pharmaceuticals S.p.A. (SWX: NWRN)

Newron Pharmaceuticals Revenue

In the year 2023, Newron Pharmaceuticals had annual revenue of 17.20M EUR, down -4.27%. Newron Pharmaceuticals had revenue of 9.42M in the half year ending December 31, 2023, with 99.17% growth.

• Revenue: 17.20M EUR
• Revenue Growth: -4.27%
• P/S Ratio: 17.97
• Revenue / Employee: 781.77K EUR
• Employees: 22
• Market Cap: 161.81M CHF

Revenue Chart

* This company reports financials in EUR.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	17.20M	-768.00K	-4.27%
Dec 31, 2022	17.97M	-959.00K	-5.07%
Dec 31, 2021	18.93M	-2.71M	-12.52%
Dec 31, 2020	21.63M	5.64M	35.25%
Dec 31, 2019	16.00M	-32.29M	-66.87%